Perioperative Durvalumab Does Not Impact Surgical Outcomes in NSCLC
Perioperative durvalumab does not adversely impact surgical outcomes in patients with resectable non-small cell lung cancer, data suggest.
Source: cancertherapyadvisor.com
Bridge Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Bridge Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Bridge Bio Today - Breaking & Trending Today
AI Deployed in Lung Disease Trial
U.K. medtech Brainomix is partnering with South Korean Bridge Bio to deploy AI in a Phase II trial of the investigational drug BBT-877 in progressive lung disease.
Source: insideprecisionmedicine.com
Lexaria Bioscience Corp.: Lexaria Discusses Valuation Metrics for Biotech Industry
Third Party Analysis for Biotech and Pharma IndustriesKELOWNA, BC / ACCESSWIRE / August 11, 2022 / Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator
Source: finanznachrichten.de